Rina Tanaka

Hirosaki, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Real-world safety and efficacy of enzalutamide versus darolutamide in nonmetastatic castration-resistant prostate cancer: a multicenter retrospective study.

Real-world safety and efficacy of enzalutamide versus darolutamide in nonmetastatic castration-resistant prostate cancer: a multicenter retrospective study.

Journal: ESMO real world data and digital oncology

Published: July 13, 2026

Authors' reply to "Reconsidering prostate cancer screening: limitations of net survival and the primacy of overall survival as an endpoint".

Authors' reply to "Reconsidering prostate cancer screening: limitations of net survival and the primacy of overall survival as an endpoint".

Journal: Japanese journal of clinical oncology

Published: April 20, 2026

Comments on 'Survival by Detection Pathway in Patients With Lung Cancer: A Nationwide Descriptive Epidemiological Study in Japan'.

Comments on 'Survival by Detection Pathway in Patients With Lung Cancer: A Nationwide Descriptive Epidemiological Study in Japan'.

Journal: International journal of cancer

Published: April 16, 2026

Influence of the COVID-19 pandemic on cancer incidence in Japan

Influence of the COVID-19 pandemic on cancer incidence in Japan

Journal: [Nihon koshu eisei zasshi] Japanese journal of public health

Published: March 04, 2026

Trends in net survival for 1,834,894 patients with cancer from 16 population-based cancer registries in Japan, 2000-14 (CONCORD-3).

Trends in net survival for 1,834,894 patients with cancer from 16 population-based cancer registries in Japan, 2000-14 (CONCORD-3).

Journal: Japanese journal of clinical oncology

Published: October 17, 2025

Trends in survival for patients with esophageal cancer in Japan, 2000-14 (CONCORD-3).

Trends in survival for patients with esophageal cancer in Japan, 2000-14 (CONCORD-3).

Journal: Japanese journal of clinical oncology

Published: September 09, 2025

Trends in 5-year net survival for women diagnosed with breast, cervical or ovarian cancer in Japan, 2000-14 (CONCORD-3).

Trends in 5-year net survival for women diagnosed with breast, cervical or ovarian cancer in Japan, 2000-14 (CONCORD-3).

Journal: Japanese journal of clinical oncology

Published: June 17, 2025

Trends in net survival for patients with brain tumors in Japan, 2000-14 (CONCORD-3).

Trends in net survival for patients with brain tumors in Japan, 2000-14 (CONCORD-3).

Journal: Japanese journal of clinical oncology

Published: June 05, 2025

Overexpression of CDT1 inhibits cell cycle progression at S phase by interacting with the mini-chromosome maintenance complex and causes DNA damage.

Overexpression of CDT1 inhibits cell cycle progression at S phase by interacting with the mini-chromosome maintenance complex and causes DNA damage.

Journal: FEBS open bio

Published: April 23, 2025

Trends in survival for adult patients with hematopoietic malignancies in Japan, 2000-14 (CONCORD-3).

Trends in survival for adult patients with hematopoietic malignancies in Japan, 2000-14 (CONCORD-3).

Journal: Japanese journal of clinical oncology

Published: April 03, 2025

Trends in survival for children with brain tumors, acute lymphoblastic leukemia, and lymphomas in Japan, 2000-14 (CONCORD-3).

Trends in survival for children with brain tumors, acute lymphoblastic leukemia, and lymphomas in Japan, 2000-14 (CONCORD-3).

Journal: Japanese journal of clinical oncology

Published: March 14, 2025

Trends in survival for patients with lung cancer in Japan, 2000-14 (CONCORD-3).

Trends in survival for patients with lung cancer in Japan, 2000-14 (CONCORD-3).

Journal: Japanese journal of clinical oncology

Published: February 18, 2025

Showing 1-12 of 44

Last Updated: 09/26/2026